| | |

News Hy BioPharma Enters Phase III Development with its Lead Drug Hypericin for Topical Phototherapy of Skin Lymphoma May 29 2008   File 1   File 2   File 3 . Innovating with photodynamic therapeutics: Hy BioPharma develops hypericin for cancer and other diseases July/August 2008   .

Home Page | Management team | Scientific Advisory Board
Hypericin Oncology | Hypericin Autoimmune Diseases | Pipeline | HBP-412 Autoimmune Diseases
Articles | Links | Contact us